CM
FOLD

Caption Management’s Amicus Therapeutics FOLD Stock Holding History

Caption Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50,000
Closed -$394K – 1748
2025
Q3 		$394K Buy
+50,000
New +$356K ﹤0.01% 1355
2025
Q2 		– Sell
-241,700
Closed -$1.97M – 1611
2025
Q1 		$1.97M Buy
241,700
+143,600
+146% +$1.33M 0.02% 683
2024
Q4 		$924K Buy
+98,100
New +$1.02M 0.01% 940
2024
Q3 		– Sell
-35,000
Closed -$347K – 1394
2024
Q2 		$347K Sell
35,000
-53,700
-61% -$551K 0.01% 872
2024
Q1 		$1.04M Sell
88,700
-128,100
-59% -$1.64M 0.02% 719
2023
Q4 		$3.08M Buy
216,800
+41,800
+24% +$475K 0.04% 492
2023
Q3 		$2.13M Buy
175,000
+95,000
+119% +$1.23M 0.03% 561
2023
Q2 		$1M Sell
80,000
-60,000
-43% -$712K 0.02% 665
2023
Q1 		$1.55M Buy
140,000
+40,000
+40% +$493K 0.03% 517
2022
Q4 		$1.22M Buy
+100,000
New +$1.13M 0.02% 685
2022
Q3 		– Sell
-100,000
Closed -$1.07M – 1619
2022
Q2 		$1.07M Buy
+100,000
New +$824K 0.01% 860
2021
Q3 		– Sell
-50,000
Closed -$482K – 1603
2021
Q2 		$482K Sell
50,000
-200,000
-80% -$1.95M 0.01% 1047
2021
Q1 		$2.47M Sell
250,000
-360,000
-59% -$5.57M 0.05% 455
2020
Q4 		$14.1M Buy
610,000
+460,000
+307% +$9.41M 0.32% 77
2020
Q3 		$2.12M Buy
150,000
+90,000
+150% +$1.31M 0.05% 411
2020
Q2 		$905K Buy
60,000
+20,000
+50% +$244K 0.03% 556
2020
Q1 		$370K Buy
+40,000
New +$380K 0.02% 599
2019
Q4 		– Sell
-20,000
Closed -$160K – 899
2019
Q3 		$160K Hold
20,000
– – 0.01% 608
2019
Q2 		$249K Buy
+20,000
New +$254K 0.01% 545

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Caption Management's FOLD Position: Q4 2025 in Review

Caption Management sold out of Amicus Therapeutics (FOLD) in Q4 2025, closing a stake of 11,100 shares — an estimated $109K sold.

Caption Management first reported a position in FOLD in Q1 2018 and held it in 16 quarters. The position peaked at $4.61M in Q4 2020. 332 funds tracked by Wall St. Rank hold FOLD as of Q4 2025.

  • Caption Management reported no remaining Amicus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Caption Management sold 11,100 Amicus Therapeutics shares in Q4 2025, an estimated $109K.
  • Caption Management first reported a position in Amicus Therapeutics in Q1 2018 and held it in 16 quarters.
  • Caption Management's Amicus Therapeutics position peaked at $4.61M in Q4 2020.
  • 332 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.